Oscanoa TJ, Julca DI, Lapeyre-Rivera A, Jiménez-Pelayo A, Julón-Buitrón J, Limache-Canaza L, Juárez-Pérez E, Julca- Alvarado J, Londoñe-Sullca R, Liñer-Mendoza C, Lavado-Degracia P, Lázaro-Ríos L. Elevated tocilizumab-induced transaminase levels during treatment for severe SARS-CoV-2 infection: Meta-analytical study. spmi [Internet]. 2022Mar.6 [cited 2024May20];35(1):8.12. Available from: https://www.revistamedicinainterna.net/index.php/spmi/article/view/649